Several influenza antiviral drugs have been approved by the US Food and Drug Administration (FDA); oseltamivir, zanamivir, amantadine and rimantadine, these drugs mainly target two of the viral proteins, neuraminidase (NA) and the M2 ion channel protein [25]. This evidence concerns the gene XK and influenza.